Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Bauernhofer Emil Thomas |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Bauernhofer, ET; Moser, T; Eberhard, A; Monsberger, N; Moser, MJ; Glawitsch, L; Hammer, S; Vlachos, G; Ziegler, L; Geigl, JB; Bauernhofer, T; Heitzer, E
Plasma-derived ctDNA outperforms urinary ctDNA as a prognostic biomarker in metastatic prostate cancer
ANN ONCOL. 2025; 36: -ESMO Congress 2025; OCT 17-21, 2025; Berlin, GERMANY.
Doi: 10.1016/j.annonc.2025.08.3135
[Poster]
Web of Science
FullText
FullText_MUG
Moser, T; Bauernhofer, E; Eberhard, A; Monsberger, N; Moser, MJ; Glawitsch, L; Hammer, S; Vlachos, G; Ziegler, L; Geigl, JB; Bauernhofer, T; Heitzer, E
Beyond Blood? Assessing the prognostic and complementary role of urinary ctDNA in metastatic prostate cancer.
7th Advances in Circulating Tumor Cells meeting: “Liquid Biopsy: from Bench to Bedside”. 2025; -ACTC; SEP 24-27, 2025; Thessaloniki, GREECE.
[Poster]
Moser, T; Bauernhofer, E; Eberhard, A; Monsberger, N; Vlachos, G; Moser, MJ; Glawitsch, L; Hammer, S; Ziegler, L; Geigl, JB; Bauernhofer, T; Heitzer, E
Beyond Blood: Can Urinary ctDNA Expand the Diagnostic Window in Advanced Prostate Cancer?
14th International Symposium on Circulating Nucleic Acids in Plasma and Serum. 2025; -CNAPS; DEC 3-5, 2025; Hong Kong, CHINA.
[Poster]
Vlachos, G; Moser, T; Lazzeri, I; Moser, MJ; Bauernhofer, ET; Eberhard, A; Blatterer, J; Kühberger, S; Monsberger, N; Kashofer, K; Geigl, JB; Bauernhofer, T; Heitzer, E
Multimodal cfDNA profiling reveals functional homologous recombination deficiency in prostate cancer.
Advances in Circulating Tumor Cells (ACTC); SEP 24-27, 2025; Thessaloniki, GREECE. 2025.
[Oral Communication]
Vlachos, G; Sadeghi, H; Moser, T; Lazzeri, I; Moser, MJ; Glawitsch, L; Bauernhofer, ET; Eberhard, A; Beichler, C; Blatterer, J; Kühberger, S; Monsberger, N; Terbuch, A; Kashofer, K; Geigl, JB; Bauernhofer, T; Heitzer, E
Functional Homologous Recombination Deficiency in Prostate Cancer Revealed Through Multimodal cfDNA Profiling.
14th CNAPS International Symposium, Hong Kong. 2025; -14th CNAPS International Symposium (CNAPS 2025); DEC 3-5, 2025; Hong Kong, CHINA.
[Poster]
Moser, T; Eberhard, A; Moser, MJ; Glawitsch, L; Hammer, S; Vlachos, G; Lazzeri, I; Ziegler, L; Bauernhofer, E; Monsberger N; Geigl, JB; Bauernhofer, T; Heitzer, E
Linking liquids: cfDNA in urine and plasma as informative allies in metastasized prostate cancer.
Annual Meeting 2024. 2024; -AACR; APR 5-10, 2024; San Diego, USA.
[Poster]
FullText
Vlachos, G; Moser, T; Eberhard, A; Glaswitch, L; Blatterer, J; Bauernhofer, E; Monsberger, N; Kashofer, K; Geigl, JB; Bauernhofer, T; Heitzer, E
Non-invasive detection of homologous recombination deficiency in metastatic prostate cancer patients.
Annual Meeting. 2024; -AACR 2024; APR 5-10, 2024; San Diego, USA;.
[Poster]
FullText